The global oncology sector is witnessing rapid transformation, driven by increasing incidence of aggressive brain tumors such as malignant gliomas in adults. Rising prevalence, coupled with advancements in precision medicine, immunotherapy, and targeted therapies, is significantly reshaping treatment approaches. Continuous innovation in drug development, along with growing investments in...